OTCMKTS:SWTUY SWEDISH ORPHAN/S (SWTUY) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SWTUY Stock Alerts $24.38 -0.29 (-1.18%) (As of 04/9/2019) Add Compare Share Share Today's Range$24.38▼$24.3850-Day Range$24.38▼$24.3852-Week Range$18.50▼$31.96Volume200 shsAverage Volume1,665 shsMarket Capitalization$6.64 billionP/E Ratio48.76Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get SWEDISH ORPHAN/S alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About SWEDISH ORPHAN/S Stock (OTCMKTS:SWTUY)Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haemophilia, inflammation, and genetic and lysosomal diseases. The company offers Elocta to treat haemophilia A; and Alprolix to treat haemophilia B. It also provides Orfadin for the treatment of hereditary tyrosinaemia type 1; and Kineret for the treatment of auto inflammatory condition, as well as Xiapex to treat Dupuytren's contracture and Peyronie's disease. In addition, the company manufactures drug substance for ReFacto AF; and develops BIVV001 and BIVV002 for the treatment of hemophilia. It operates in Sweden, the Middle East, North Africa, Russia, North America, other European countries, and internationally. The company has an agreement with Bioverativ for the development and commercialization of Elocta and Alprolix, as well as XTEN-programs. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden.Read More SWTUY Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SWTUY Stock News HeadlinesApril 8, 2024 | msn.comMore premature babies born following Swedish parental leave policyApril 3, 2024 | msn.comSwedish Scientists Confirm: Knitting Is Your Brain's Best FriendApril 23, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.March 30, 2024 | msn.comBulgarian cruise ship crashes into wall on Danube in Austria, injuring 11March 17, 2024 | msn.comCrown Princess Victoria of Sweden, Swedish Minister Johan Forssell to visit Bangladesh March 18-21March 7, 2024 | msn.comSweden set to become NATO's 32nd member as PM visits WashingtonFebruary 21, 2024 | msn.comDeath and grief in Swedish children's booksFebruary 19, 2024 | msn.comUPDATE 2-Sweden's Vattenfall to move ahead with nuclear plansApril 23, 2024 | Insiders Exposed (Ad)The Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.February 12, 2024 | finanznachrichten.deOrexo and Sobi agree to advance feasibility study with AmorphOXFebruary 10, 2024 | msn.comRevolutionizing Historical Research: Swedish Lion AI UnveiledFebruary 8, 2024 | markets.businessinsider.comHere's what Wall Street expects from Swedish Orphan Biovitrum AB's earnings reportFebruary 6, 2024 | msn.comClues from the ice age can help restore Swedish streamsJanuary 19, 2024 | forbes.comA Day Trip To Uppsala, Sweden’s City Of HistoryJanuary 18, 2024 | msn.comSweden's call for population to prepare for war sparks panic and criticismJanuary 11, 2024 | msn.comScientists Unearth Centuries-Old Secrets From Swedish ShipwreckJanuary 11, 2024 | msn.comSwedish Shipwreck Gives Inside Look at Life for Baltic Sailors Centuries AgoJanuary 10, 2024 | msn.comSwedish £6,000 dine and dash investigation reopenedJanuary 10, 2024 | msn.com'Prepare for war!' Swedish government tells citizens to prepare for the worstJanuary 4, 2024 | msn.comSwedish snow chaos leaves 1,000 vehicles trappedJanuary 4, 2024 | msn.comUkrainian orphan Natalia Grace’s DNA test confirms her real age after she’s accused of ‘masquerading’ as a child, trying to kill parentsJanuary 3, 2024 | msn.comSweden’s Coop confirms cyberattack on Värmland storesJanuary 2, 2024 | msn.comRadiographic study exposes ancient oral health of Swedish VikingsDecember 30, 2023 | msn.com'Santa Claus' Triggers Bomb Scare at Swedish AirportJune 9, 2022 | benzinga.comCytokine Release Syndrome Market Research Report 2022 Featuring Genentech, Novartis, Incyte, CytoSorbents, Jazz Pharma, Swedish Orphan BiovitrumJune 2, 2022 | finanznachrichten.deSwedish Orphan Biovitrum AB: Sobi: FDA grants efanesoctocog alfa Breakthrough Therapy designation for haemophilia AJune 1, 2022 | markets.businessinsider.comSanofi: FDA Grants Efanesoctocog Alfa Breakthrough Therapy Designation For Hemophilia ASee More Headlines Receive SWTUY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SWEDISH ORPHAN/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Private Households Sub-IndustryN/A Current SymbolOTCMKTS:SWTUY Previous SymbolNASDAQ:SWTUY CUSIPN/A CIKN/A Webwww.sobi.com Phone46-0-869-720-00FaxN/AEmployees902Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.50 Trailing P/E Ratio48.76 Forward P/E RatioN/A P/E Growth1.3Net Income$134.73 million Net Margins25.75% Pretax MarginN/A Return on Equity29.63% Return on Assets18.74% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$763.19 million Price / Sales8.71 Cash Flow$0.70 per share Price / Cash Flow34.66 Book Value$2.88 per share Price / Book8.47Miscellaneous Outstanding Shares272,508,000Free FloatN/AMarket Cap$6.64 billion OptionableNot Optionable Beta1.81 7 Stocks That Could Be Bigger Than Tesla, Nvidia, and GoogleGrowth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.Get This Free Report Key ExecutivesDr. Guido Oelkers (Age 54)CEO & Pres Mr. Henrik Stenqvist (Age 52)Chief Financial Officer Ms. Anne Marie de Jonge SchuermansHead of Technical OperationsMs. Paula Treutiger (Age 52)Head of Communications & Investor Relations Mr. Torbjörn Hallberg (Age 50)Gen. Counsel & Head of Legal Affairs Key CompetitorsSino BiopharmaceuticalOTCMKTS:SBMFFAmplifonOTCMKTS:AMFPFRamsay Health CareOTCMKTS:RMYHYAurora CannabisOTCMKTS:ACBFFHikma PharmaceuticalsOTCMKTS:HKMPFView All Competitors SWTUY Stock Analysis - Frequently Asked Questions How have SWTUY shares performed in 2024? SWEDISH ORPHAN/S's stock was trading at $24.38 at the beginning of 2024. Since then, SWTUY stock has increased by 0.0% and is now trading at $24.38. View the best growth stocks for 2024 here. How do I buy shares of SWEDISH ORPHAN/S? Shares of SWTUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SWTUY) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithSHOCKING Crypto Leak…Crypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SWEDISH ORPHAN/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
